Medibank Private (MPL.AX) Aktsia Kursus
Medibank Private Kursus
Käive kasvas 5,8 % aastas viimase 19 aasta jooksul 9,33 B AUD-ni. Kasum aktsia kohta kasvas 8,1 % aastas viimase 13 aasta jooksul. Medibank Private netomarginaal on nüüd 6,8 %, tõusnud 5,6 %-lt mõni aasta tagasi. Medibank Private pakub praegu umbes 2,31 % dividenditootlust. Väljamaksesuhe on umbes 129 % kasumist. Dividend kasvas 4,2 % aastas viimase 11 aasta jooksul. Analüütikute hinnasihi mediaan on 5,00 AUD, st alla praegust hinda 2,7 %. 14 analüütikust 5 soovitab osta — üldine konsensus on Hoia.
Medibank Private aktsiahinnad
Hangi need andmed Eulerpool API kaudu
100 000 päringut/kuus tasuta · krediitkaarti pole
Medibank Private ärimudel ja aktsia analüüs
Korduma kippuvad küsimused Medibank Private aktsia kohta
Medibank Private Ltd operates as a leading private health insurance provider in Australia. The company's business model revolves around offering health insurance products and services to a wide range of individuals and families. Medibank Private aims to ensure accessibility, affordability, and quality healthcare for its customers. The company's model focuses on providing comprehensive coverage, including hospital treatment, specialist consultations, and ancillary services. By leveraging its extensive network of healthcare providers and utilizing advanced technological solutions, Medibank Private delivers value-based and customer-centric healthcare solutions. With a strong emphasis on innovation and customer satisfaction, Medibank Private continues to serve as a reliable and trusted health insurance partner.
Medibank Private Ltd is primarily active in the healthcare industry.
The main competitors of Medibank Private Ltd in the market include Bupa Australia, HCF, NIB Holdings Ltd, and HBF Health Limited.
Medibank Private Ltd is an Australian private health insurance company. It was established in 1976 as a government-owned entity to provide affordable health coverage to Australians. Initially, it operated as a not-for-profit organization until it was privatized in 2014 and listed on the Australian Securities Exchange (ASX). Since then, Medibank has evolved into a leading health insurer, offering a wide range of health insurance products and services to individuals, families, and businesses across Australia. With a strong focus on customer satisfaction and innovative healthcare solutions, Medibank Private Ltd continues to play a vital role in ensuring the well-being of millions of Australians.
Medibank Private Ltd, Australia's leading health insurer, has achieved several significant milestones throughout its history. One of the key achievements was its successful initial public offering (IPO) in 2014, marking its transition from a government-owned entity to a publicly listed company. Since then, Medibank has consistently delivered strong financial performance, demonstrating its commitment to shareholder value. The company has also expanded its services by introducing innovative healthcare programs and partnerships, aimed at improving the health and well-being of its members. Medibank's focus on customer satisfaction and high-quality healthcare has enabled it to become a trusted name in the industry, further reinforcing its position as a market leader.
Medibank Private Ltd is primarily present in Australia. This leading private health insurance provider operates predominantly in its home country, catering to a wide customer base. With its headquarters located in Melbourne, Medibank Private Ltd offers a range of health insurance services and products to individuals, families, and businesses across Australia.
Medibank Private Ltd represents a commitment to delivering high-quality healthcare services to its customers. The company values customer satisfaction and aims to provide accessible and affordable healthcare for all Australians. Medibank Private Ltd places importance on innovation, investing in new technologies and approaches to improve healthcare outcomes. With a focus on corporate responsibility, the company aims to make a positive impact on the health and wellbeing of individuals and communities. Medibank Private Ltd strives to be a trusted and customer-centric healthcare provider, ensuring the utmost care and support for its customers' health needs.
Analüütikud määravad Medibank Private aktsiale keskmiseks hinnasihi 5,22 AUD (mediaan: 5,00 AUD), mis on +1,5 % viimase hinna suhtes. Konsensus põhineb 14 analüütiku hinnangul.
14 analüütikut hindavad praegu Medibank Private aktsiat: 5 soovitab osta, 9 hoida ja 0 müüa.
Praeguse kursiga kaubeldakse Medibank Private aktsiaga 3,20 EUR (5,14 AUD) juures.
Medibank Private aktsia (MPL.AX) on noteeritud 5 börsil, sh: SIX (Zürich) (MPV.SW), ASX (MPL.AX), Frankfurt (MPV.F), München (MPV.MU), Düsseldorf (MPV.DU).
Medibank Private Ltd is a leading Australian health insurance company that provides its customers with high-quality health solutions and medical services. The company operates in four main areas: health insurance, health services, private hospitals, and life insurance. It offers a wide range of health insurance products and services, including individual and family plans, group plans for businesses, and a variety of health services such as home visits, telemedicine, and emergency services. The private hospital division provides access to top-notch facilities and medical services. The company also offers life insurance products and services, including life insurance, income protection insurance, and accident insurance. Medibank Private aims to improve the customer experience through innovative technologies and digital services, offering tools and applications to manage and improve health and lifestyle. Overall, Medibank Private has a strong business model focused on providing high-quality health solutions and medical services, with a strong market position and a commitment to expanding its product and service offerings to meet the changing needs of its customers.
Medibank Private käive on 9,33 B AUD. See näitaja põhineb praegusel finantsandmetel ja peegeldab ettevõtte äritulemuseid.
Medibank Private kasum on 638,70 M AUD. Netokasum peegeldab ettevõtte kasumlikkust pärast kõigi kulude mahaarvamist.
Võrdlusarvud hinna ja kasumiga (P/E) Medibank Private jaoks on praegu 22,14. P/E-suhtarv võrdleb praegust aktsiahinnad kasumiga aktsia kohta ja aitab investoritel hinnata Medibank Private aktsia väärtust.
Kursuse ja müügimahu suhe (P/S) Medibank Private jaoks on praegu 1,52. P/S-suhtarv võrdleb börsikapitalisatsooni aastase tuluga ja teenib hindamismõõdikuna Medibank Private aktsia jaoks.
Eulpooli kvaliteedinäitaja Medibank Private jaoks on 7/10.
Medibank Private ISIN on AU000000MPL3. ISIN (rahvusvaheline väärtpaberi identifitseerimise number) on väärtpaberite globaalne unikaalne tuvastaja.
Medibank Private WKN on A12D1W. WKN (Wertpapierkennnummer) on kuuekohaline saksa väärtpaberi identifitseerimise number.
Medibank Private ticker on MPL.AX. Ticker-sümbol kasutatakse Medibank Private aktsiate kauplemiseks börsil.
Medibank Private aktsia
Medibank Private konkurendid
Medibank Private Börsiticker
Medibank Private FIGI
Kõik teised näitajad ja analüüsid Medibank Private kohta sügavamalt
Meie Medibank Private-aktsia analüüs sisaldab olulisi finantsnäitajaid, nagu käive, kasum, P/E suhe, P/S suhe, EBIT, samuti teavet dividendi kohta. Lisaks käsitleme aspekte nagu aktsiad, turukapitalisatsioon, võlad, omakapital ja kohustused ettevõttes Medibank Private. Kui otsite nende teemade kohta põhjalikumat teavet, pakume teile meie alamlehtedel üksikasjalikke analüüse: